FMIFL
FMIFL is an FPR1 agonist. fMIFL can activate several signaling pathways responsible for various neutrophil functions, such as adhesion, chemotaxis, secretion of granule exocytosis, and the production of superoxide anions. fMIFL can be used in research on bacterial infections and tissue damage[1].
Product Specifications
CAS Number
112275-26-0
UNSPSC
12352209
Target
Bacterial; Formyl Peptide Receptor (FPR)
Type
Peptides
Related Pathways
Anti-infection; GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/fmifl.html
Purity
99.79
Solubility
H2O : 7.1 mg/mL (ultrasonic; warming; adjust pH to 8 with NH4OH)
Smiles
O=C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CC(C)C)C(O)=O)=O)=O)[C@H](CCSC)NC=O
Molecular Formula
C27H42N4O6S
Molecular Weight
550.71
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cyclin D3 (CCND3) (NM_001760) Human Over-expression Lysate
Prohibitin (Mitochondrial Marker) (PHB/3230), CF405S conjugate, 0.1mg/mL
